LEADER 01356nam  2200433   450 
001 9910707231103321
005 20160624081253.0
035   $a(CKB)5470000002463199
035   $a(OCoLC)952173514
035   $a(OCoLC)995470000002463199
035   $a(EXLCZ)995470000002463199
100   $a20160624d2004      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aUpdate $eexcessive Medicare reimbursement for ipratropium bromide
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2004.
215   $a1 online resource (v, 11 pages) $cillustration
300   $aTitle from title screen (viewed June 23, 2016).
300   $a"January 2004."
300   $a"OEI-03-03-00520."
517   $aUpdate 
606   $aMedicare$xCosts
606   $aBromine compounds$zUnited States$xCosts
606   $aDrugs$xPrices$zUnited States
606   $aPharmaceutical services insurance$zUnited States
615  0$aMedicare$xCosts.
615  0$aBromine compounds$xCosts.
615  0$aDrugs$xPrices
615  0$aPharmaceutical services insurance
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707231103321
996   $aUpdate$92038694
997   $aUNINA